Symbol Name ID |
Prdm2
PR domain containing 2, with ZNF domain MGI:107628 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Prdm2tm1Shg/Prdm2+ involves: 129S2/SvPas * C57BL/6 |
increased B cell derived lymphoma incidence | J:71406 |
increased hemangiosarcoma incidence | J:71406 | |
increased lung adenocarcinoma incidence | J:71406 | |
increased lymphoma incidence | J:71406 | |
increased pituitary adenoma incidence | J:71406 | |
increased tumor incidence | J:71406 | |
premature death | J:71406 | |
Prdm2tm1Shg/Prdm2tm1Shg involves: 129S2/SvPas * C57BL/6 |
increased B cell derived lymphoma incidence | J:71406 |
increased hemangiosarcoma incidence | J:71406 | |
increased lung adenocarcinoma incidence | J:71406 | |
increased lymphoma incidence | J:71406 | |
increased pituitary adenoma incidence | J:71406 | |
increased tumor incidence | J:71406 | |
premature death | J:71406 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|